Skip to main content
. 2022 Mar 10;76(2):434–445. doi: 10.1007/s12020-022-03020-z

Table 1.

Biochemical results from AVS

Peripheral Left adrenal Right adrenal SI
Left
SI
Right
LI
L/R ratio
LI
R/L ratio
Patient 1
 Cortisol [µg/dl] 6.4 28.1 27.6 4.4 4.3 1.0
 Aldosterone [ng/l] 78.7 342.3 241.8 4.3 3.1 1.4
 Metanephrine [pg/ml]
 Normetanephrine [pg/ml]
 DHEA-S [µg/ml] 2.6 2.9 3.1 1.1 1.2 1.1
 Androstenedione [ng/ml]
Patient 2
 Cortisol [µg/dl] 15.1 106 35.8 7.0 2.4 3.0
 Aldosterone [ng/l]
 Metanephrine [pg/ml]
 Normetanephrine [pg/ml]
 DHEA-S [µg/ml] <0.1 <0.1 0.2 1 4 11.8
 Androstenedione [ng/ml]
Patient 3
 Cortisol [µg/dl] 16.8 44.3 32.8 2.6 2.0 1.4
 Aldosterone [ng/l] <35 58.2 83.2 3.3 4.8 1.9
 Metanephrine [pg/ml]
 Normetanephrine [pg/ml]
 DHEA-S [µg/ml]
 Androstenedione [ng/ml]
Patient 4
 Cortisol [µg/dl] 22.9 127.2 125.7 5.6 5.5 1.0
 Aldosterone [ng/l] <35 110 116 6.3 6.6 1.1
 Metanephrine [pg/ml] <36 87 365 4.8 20.3 4.2
 Normetanephrine [pg/ml] <48 52 100 2.2 4.2 1.9
 DHEA-S [µg/ml]
 Androstenedione [ng/ml]
Patient 5
 Cortisol [µg/dl] 12.9 37.7 271.9 2.9 21.1 7.2
 Aldosterone [ng/l] <35 1720 272 98.3 15.5 45.6
 Metanephrine [pg/ml]
 Normetanephrine [pg/ml]
 DHEA-S [µg/ml]
 Androstenedione [ng/ml]
Patient 6
 Cortisol [µg/dl] 10.8 512 616.8 47.4 57.1 1.2
 Aldosterone [ng/l]
 Metanephrine [pg/ml] <36 5987 2288 332.6 127.1 3.2
 Normetanephrine [pg/ml] 66 1617 568 24.5 8.6 3.4
 DHEA-S [µg/ml]
 Androstenedione [ng/ml]
Patient 7
 Cortisol [µg/dl] 8.6 38.9 216.9 4.5 25.2 5.6
 Aldosterone [ng/l]
 Metanephrine [pg/ml] 40 88 2105 2.2 52.6 4.3
 Normetanephrine [pg/ml] <48 <48 552 1.0 23 4.1
 DHEA-S [µg/ml]
 Androstenedione [ng/ml]
Patient 8
 Cortisol [µg/dl] 10.4 633.5 50.9 60.9 4.9 12.5
 Aldosterone [pg/ml] 239 1840 2190 7.7 9.2 14.8
 Metanephrine [pg/ml] <36 2096 1005 116.4 55.8 6
 Normetanephrine [pg/ml] <48 601 371 25 15.5 7.7
 DHEA-S [µg/ml]
 Androstenedione [ng/ml]
Patient 9
 Cortisol [µg/dl] 7.8 179 17 22.9 2.2 10.5
 Aldosterone [ng/l] <35 179 220 10.2 12.6 12.9
 Metanephrine [pg/ml]
 Normetanephrine [pg/ml]
 DHEA-S [µg/ml]
 Androstenedione [ng/ml]
Patient 10
 Cortisol [µg/dl] 11.7 41.3 271.7 3.5 23.2 6.6
 Aldosterone [pg/ml] 86 140 357 1.6 4.2 2.6
 Metanephrine [pg/ml]
 Normetanephrine [pg/ml]
 DHEA-S [µg/ml]
 Androstenedione [ng/ml] <0.24 9.4 24.24 78.3 202 2.6
Patient 11
 Cortisol [µg/dl] 14.5 154.8 32.4 10.7 2.2 4.8
 Aldosterone [pg/ml] 94 1270 329 13.5 3.5 1.2
 Metanephrine [pg/ml]
 Normetanephrine [pg/ml]
 DHEA-S [µg/ml]
 Androstenedione [ng/ml] 0.66 7.94 7.25 12.0 11.0 4.4
Patient 12
 Cortisol [µg/dl] 9.0 23.7 39.7 2.6 4.4 1.7
 Aldosterone [pg/ml] 52 239 277 4.6 5.3 1.4
 Metanephrine [pg/ml]
 Normetanephrine [pg/ml]
 DHEA-S [µg/ml]
 Androstenedione [ng/ml]
Patient 13
 Cortisol [µg/dl] 10.6 35.6 22.0 3.4 2.1 1.6
 Aldosterone [ng/l] 37 63 315 1.7 8.5 8.1
 Metanephrine [pg/ml]
 Normetanephrine [pg/ml]
 DHEA-S [µg/ml]
 Androstenedione [ng/ml]
Patient 14
 Cortisol [µg/dl] 12.4 74.3 46.9 6.0 3.8 1.6
 Aldosterone [ng/l] 37 1415 420 38.2 11.4 2.1
 Metanephrine [pg/ml]
 Normetanephrine [pg/ml]
 DHEA-S [µg/ml]
 Androstenedione [ng/ml]
Patient 15
 Cortisol [µg/dl] 8.5 28.8 56.5 3.4 6.6 2.0
 Aldosterone [ng/l] 47 1008 >1320 21.4 28.1 1.5
 Metanephrine [pg/ml] <28 2410 1770 172 126 2.7
 Normetanephrine [pg/ml] 57 663 503 11.6 8.8 2.6
 DHEA-S [µg/ml] 0.18 0.23 0.24 1.3 1.3 1.9
 Androstenedione [ng/ml]
Patient 16
 Cortisol [µg/dl] 16.6 48.8 >75 2.9 4.5 1.5
 Aldosterone [ng/l] <37 311 667 16.8 36.1 1.4
 Metanephrine [pg/ml] 995 47 47 0.0 0.0 1.5
 Normetanephrine [pg/ml] 210 68 40 0.3 0.2 2.6
 DHEA-S [µg/ml] 0.04 0.06 0.11 1.5 2.8 1.2
 Androstenedione [ng/ml]

Lower limits of quantification: Cortisol 2 µg/dl, Aldosterone: 35 ng/ml, Metanephrine: 36 pg/ml, Normetanephrine: 48 pg/ml, DHEA-S 0.1 µg/ml, Androstenedione 0.24 ng/ml. When the concentration of the measured hormones was below the lower limit of quantification of the assay, half of the lower limit of quantification was used for calculation. Hormone concentrations above the upper limit of quantification were reported as the upper limit of quantification. The LI, which was used for the interpretation of its patient’s AVS, is marked bold. The patients’ 4 AVS was considered as bilateral, because the lateralization indices adjusted for aldosterone and normetanephrines were 1.9 and 1.1 (despite the lateralization index adjusted for metanephrines of 4.2)

SI Selectivity index, LI Lateralization index, L Left, R Right